- Background
- What we're looking for
- What we can offer you
- Q&A
Nerve pain represents a distinct and challenging pain space characterized by sensations such as burning, tingling, shooting, or electric-like pain that can disrupt daily functioning and quality of life. Consumers experiencing episodic or chronic nerve discomfort often report limited satisfaction with existing over-the-counter (OTC) solutions due to delayed onset, insufficient relief, tolerability concerns, or uncertainty around mechanisms of action and benefits.
From a scientific standpoint, nerve pain involves complex peripheral and central pathways, including altered nerve signaling, sensitization, and dysregulation of pain processing. Effective solutions depend on aligning what is combined (ingredients, actives, and delivery systems) with what is targeted (nerve pathways and mechanisms) to reliably deliver meaningful outcomes.
Advances in neurobiology, formulation science, delivery technologies, and nature-inspired actives create new opportunities to improve nerve pain relief while maintaining safety and OTC-appropriate profiles. However, the innovation landscape is fragmented, and prioritizing the most promising approaches requires a structured, outcome-driven evaluation that integrates scientific, market, and regulatory considerations. This request seeks to identify, investigate, and prioritize emerging nerve pain solutions across oral, topical, and natural-adjacent modalities with clear potential for differentiation and partnership.
We are looking for evidence-based technologies, ingredients, and solution platforms that deliver differentiated nerve pain relief across oral, topical, and natural-adjacent approaches. Ideal solutions should demonstrate a clear relationship between mechanism of action, delivery format, and nerve pain outcomes, with appropriate safety and tolerability for intended use. We welcome approaches that address peripheral and/or central nerve pain pathways and can be evaluated through a structured, stage-gated process to assess impact, feasibility, and scalability.
- Oral ingredients or systems targeting neuropathic pain mechanisms (e.g., nerve signaling, sensitization) beyond alpha-lipoic acid
- Topical technologies enabling localized nerve pain relief or peripheral desensitization
- Natural or nature-inspired solutions with evidence for nerve pain support
- Delivery and formulation platforms that enhance targeting, exposure, or tolerability for nerve pain
- Hybrid approaches addressing both peripheral and central nerve pain pathways
- Clear mechanism of action or enablement linked to nerve pain relief outcomes
- Evidence supporting performance, safety, and feasibility for intended use
- Applicability to oral, topical, or natural-adjacent nerve pain solutions
- Regulatory awareness appropriate for OTC or supplement adjacent pathways
- Demonstrated impact on nerve-related sensations (e.g., burning, tingling)
- Stage-gated metrics enabling impact vs. feasibility prioritization
- Preliminary IP clarity or freedom-to-operate insights
- Solutions without a credible path to consumer-facing nerve pain relief
- Concepts lacking technical or scientific substantiation
- Highly invasive, prescription-only, or impractical administration routes
Ask the team at the company any questions you have about this partnering request.
Other recommended requests
delivered to your inbox.